Researchers have identified eight primary factors that increase the risk of a common bleeding complication after heart attack. Some of these factors are already known, but using machine learning ...

A risk-based screening strategy shows high efficacy and significant reductions in cost in the detection of upper gastrointestinal cancers compared with conventional universal screening, results from a ...

Upper GI mucosal damage was tied to a 76% higher risk of subsequent Parkinson's disease. The retrospective study followed GI patients for nearly 15 years. The findings support literature suggesting ...

A new study casts doubt on international guidelines advising up to a week of prophylactic antibiotics in patients with cirrhosis and upper gastrointestinal (GI) bleeding. Pooled data from 14 ...

Please provide your email address to receive an email when new articles are posted on . Chan and colleagues assessed data on 19,114 patients from Aspree, an aspirin primary prevention trial. In the ...

Please provide your email address to receive an email when new articles are posted on . Evidence for metoclopramide use in upper GI bleeding is very low, with few published trial data. Existing data ...

The BREAKWATER trial demonstrated the efficacy of a BRAF-targeted regimen using FOLFIRI, offering a neuropathy-free option for metastatic colorectal cancer patients. HERIZON-GEA-01 trial results ...

Current guidelines recommend 5 to 7 days of broad-spectrum antibiotic prophylaxis for upper gastrointestinal bleeding in patients with cirrhosis. In a systematic review and meta-analysis, shorter ...

Upper gastrointestinal (GI) bleeding refers to bleeding that occurs anywhere in the esophagus, the stomach, or the upper part of the small intestine. It is a symptom of an underlying disorder, and it ...